GIUSTINA, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 1.348
EU - Europa 1.232
AS - Asia 225
AF - Africa 43
OC - Oceania 18
SA - Sud America 12
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.879
Nazione #
US - Stati Uniti d'America 1.329
SE - Svezia 815
IT - Italia 153
IE - Irlanda 63
IN - India 62
FI - Finlandia 53
DE - Germania 49
IR - Iran 36
CN - Cina 34
EG - Egitto 33
GB - Regno Unito 22
AU - Australia 16
FR - Francia 16
CA - Canada 14
ES - Italia 14
HK - Hong Kong 13
SG - Singapore 13
CH - Svizzera 11
IL - Israele 10
TW - Taiwan 10
ID - Indonesia 9
JP - Giappone 9
RU - Federazione Russa 9
TR - Turchia 9
TN - Tunisia 8
BR - Brasile 6
NL - Olanda 6
DK - Danimarca 5
MX - Messico 5
PK - Pakistan 5
GR - Grecia 4
IQ - Iraq 4
PE - Perù 4
PH - Filippine 3
SA - Arabia Saudita 3
AT - Austria 2
EC - Ecuador 2
JO - Giordania 2
MA - Marocco 2
ME - Montenegro 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
RO - Romania 2
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
EU - Europa 1
IS - Islanda 1
KR - Corea 1
LK - Sri Lanka 1
UA - Ucraina 1
VN - Vietnam 1
Totale 2.879
Città #
Princeton 394
Lawrence 393
Ashburn 144
Dublin 62
Milan 58
New York 58
Helsinki 53
Pune 52
Los Angeles 34
Giza 27
Tehran 25
Shanghai 24
Washington 24
Seattle 22
Rome 15
Hanover 10
Zurich 9
Tel Aviv 8
Kaohsiung City 7
Wilmington 7
Cairo 6
Aachen 5
Chicago 5
Melbourne 5
Naples 5
Paris 5
Torquay 5
Ankara 4
Cannon Beach 4
Denver 4
Edmonton 4
Hong Kong 4
Hyderabad 4
Jakarta 4
Villorba 4
Antibes 3
Beachwood 3
Bologna 3
Central 3
Como 3
Florence 3
Gainesville 3
Genoa 3
Istanbul 3
Leicester 3
Lima 3
London 3
Madrid 3
Mexico City 3
Naestved 3
New Taipei 3
Pau 3
Sanbornville 3
Singapore 3
St. Ingbert 3
São Paulo 3
Waldsee 3
Yogyakarta 3
A Coruña 2
Addison 2
Adelaide 2
Askim 2
Baghdad 2
Balagtas 2
Balasore 2
Bandung 2
Bari 2
Benidorm 2
Borås 2
Casarano 2
Chico 2
Columbus 2
Cricklewood 2
Cuenca 2
Dover 2
Eugene 2
Ferrara 2
Franklin 2
Frauenfeld 2
Frederiksberg 2
Goi 2
Grand Rapids 2
Greensboro 2
Groningen 2
Guadalajara 2
Hackensack 2
Harrisburg 2
Hobart 2
Houston 2
Irbid 2
Josei 2
Karachi 2
Larissa 2
Las Vegas 2
Lethbridge 2
Livingston 2
Manchester 2
Montreal 2
Moscow 2
Mumbai 2
Totale 1.647
Nome #
Low vitamin D levels are associated with Long COVID syndrome in COVID-19 survivors 377
COVID-19 and hypopituitarism 28
Adrenal schwannoma: why should endocrinologists be aware of this uncommon tumour? 25
Rugarli. Medicina interna sistematica 23
The optimal numerosity of the referral population of pituitary tumors centers of excellence (PTCOE): A surgical perspective 19
High Prevalence of Vertebral Fractures Associated With Preoperative GH Levels in Patients With Recent Diagnosis of Acromegaly 18
Weight trajectories and abdominal adiposity in COVID-19 survivors with overweight/obesity 17
High prevalence of adrenal cortical adenomas in patients with cerebral meningiomas 16
Effects of Medical Treatment of Prostate Cancer on Bone Health 16
Modern approach to resistant acromegaly 15
Pituitary tumours: inflammatory and granulomatous expansive lesions of the pituitary. 15
CURRENT AND EMERGING ASPECTS OF DIABETES MELLITUS IN ACROMEGALY. 15
High-dose and high-frequency lanreotide autogel in acromegaly: A randomized, multicenter study 15
Hypocalcemia is highly prevalent and predicts hospitalization in patients with COVID-19 15
Vitamin D in the Covid-19 era: a review with recommendations from a G.I.O.S.E.G. expert panel 15
New understanding and treatments for osteoporosis. 14
CURRENT AND FUTURE MEDICAL TREATMENTS FOR PATIENTS WITH ACROMEGALY. 14
Effects of pegvisomant and somatostatin receptor ligands on incidence of vertebral fractures in patients with acromegaly 14
Role of stroma in haemoglobin synthesis: experiments on duck red cells in vitro. 13
Morphometric vertebral fractures in breast cancer patients treated with adjuvant aromatase inhibitor therapy: A cross-sectional study 13
Are women with osteoporosis treated with denosumab at risk of severe COVID-19? 13
Adiponectin to leptin ratio reflects inflammatory burden and survival in COVID-19: Adiponectin and leptin in COVID-19 13
Radiological Thoracic Vertebral Fractures are Highly Prevalent in COVID-19 and Predict Disease Outcomes 13
Body mass index predicts resistance to active vitamin D in patients with hypoparathyroidism 13
Pituitary Tumors Centers of Excellence 13
Distinct Clinical Features of Post-COVID-19 Vaccination Early-onset Graves' Disease 12
Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement 12
[2 cases of juvenile metachronous cancer of the colon]. 12
[Intra-operative cholangiography: systematic or selective?]. 12
High prevalence of radiological vertebral fractures in women on thyroid-stimulating hormone-suppressive therapy for thyroid carcinoma 12
Skeletal fragility: an emerging complication of Ehlers–Danlos syndrome 12
A consensus on the diagnosis and treatment of acromegaly comorbidities: An update 12
Acromegaly and Vertebral Fractures: Facts and Questions 12
Consensus on diagnosis and management of Cushing's disease: a guideline update 12
Evaluation of Muscle Mass and Stiffness with Limb Ultrasound in COVID-19 Survivors 12
A CONSENSUS ON THE DIAGNOSIS AND TREATMENT OF ACROMEGALY COMPLICATIONS 11
The Hypothalamus 11
Hexarelin, a novel GHRP-6 analog, stimulates growth hormone (GH) release in a GH-secreting rat cell line (GH1) insensitive to GH-releasing hormone. 11
[Hypopituitarism secondary to suprasellar giant carotido-ophthalmic aneurysm. Normalization of the hypophyseal function after neurosurgical depression of the aneurysm]. 11
Diabetes in Cushing Disease 11
ACROMEGALY 11
Acromegalic osteopathy: An update 11
Possible delayed diagnosis and treatment of metastatic differentiated thyroid cancer by adopting the 2015 ATA guidelines 11
The Interaction of Lean Body Mass With Fat Body Mass Is Associated With Vertebral Fracture Prevalence in Women With Early Breast Cancer Undergoing Aromatase Inhibitor Therapy 10
Increased prevalence of radiological spinal deformities in active acromegaly: a cross-sectional study in postmenopausal women. 10
Influence of type 2 diabetes on functional and structrural properties of coronary artery bypass conduits 10
[Verrucous carcinoma of the penis. A case report and review of the literature]. 10
[A case of fibroangioma of the spermatic cord]. 10
Impaired growth hormone (GH) response to pyridostigmine in type 1 diabetic patients with exaggerated GH-releasing hormone-stimulated GH secretion. 10
Isradipine decreases exercise-induced albuminuria in patients with essential hypertension. 10
[Clinical usefulness of thin-needle aspiration biopsy in the diagnosis of abdominal masses]. 10
[Addison's disease and hypothyroidism]. 10
Differential inhibition of growth hormone secretion by analogs selective for somatostatin receptor subtypes 2 and 5 in human growth-hormone-secreting adenom cells in vitro. 10
Growth hormone deficiency, rapidly reversible during glucocorticoid replacement, in a case of adrenocorticotrophin deficiency. 10
[Salmon calcitonin nasal spray in the treatment of Paget's disease]. 10
[Effects of acute administration of nifedipine on exercise-induced microalbuminuria in normotensive patients with type 1 diabetes]. 10
A consensus on criteria for cure acromegaly 10
Paracentral acute middle maculopathy in central retinal vein occlusion complicating AL-amyloidosis 10
COVID-19 and the pituitary 10
Hypocalcemia in COVID-19 is associated with low vitamin D levels and impaired compensatory PTH response 10
Vitamin D Levels Are Associated with Blood Glucose and BMI in COVID-19 Patients, Predicting Disease Severity 10
In search of an ideal drug for safer treatment of obesity: The false promise of pseudoephedrine 9
Combined unsupervised and semi-automated supervised analysis of flow cytometry data reveals cellular fingerprint associated with newly diagnosed pediatric type 1 diabetes 9
Critical appraisal of definitions and diagnostic criteria for sarcopenic obesity based on a systematic review 9
Drug-induced osteoporosis:mechanism and clinical implications 9
Clinical review 136: Primary lymphoma of the pituitary: an emerging clinical entity. 9
The pharmacological aspects of the treatment of acromegaly. 9
Variability in the growth hormone response to growth hormone-releasing hormone alone or combined with pyridostigmine in type 1 diabetic patients. 9
Galanin does not affect the growth hormone-releasing hormone-stimulated growth hormone secretion in patients with hyperthyroidism. 9
Galanin decreases circulating growth hormone levels in acromegaly. 9
Optimal use of pegvisomant in acromegaly: are we getting there? 9
A retrospective hormonal and immunohistochemical evaluation of 47 acromegalic patients: prognostic value of preoperative plasma prolactin. 9
Bone ultrasonometric features and grow hormone secretion in asthmatic patients during chronic inhaled corticosteroid therapy 9
Pathophisiology of the neuroregulation of growth hormone secretion in experimental animals and in the human 9
[Simple cholecystectomy without drainage. A dilemma?]. 9
Cardiopulmonary performance during exercise in acromegaly, and the effects of acute suppression of growth hormone hypersecretion with octreotide. 9
Keep an eye on nonfunctioning pituitary adenomas. 9
Trattamento della psoriasi eritrodermica con CyA 9
[Spontaneous hematoma of the rectus abdominis muscle]. 9
Vitamin D assays and the definition of hypovitaminosis D: results from the First International Conference on Controversies in Vitamin D 9
Vitamin D and Glucocorticoid-Induced Osteoporosis 9
Correction to: Effects of pegvisomant and somatostatin receptor ligands on incidence of vertebral fractures in patients with acromegaly (Pituitary, 10.1007/s11102-018-0873-7) 9
Hypertrophic remodeling of subcutaneous small resistance arteries in acromegalic patients 9
Low-dose octreotide is able to cause a maximal inhibition of the glycemic responses to a mixed meal in obese type 2 diabetic patients treated with insulin. 9
Clinical Biology of the Pituitary Adenoma 8
Effects of Pegvisomant and Pasireotide LAR on Vertebral Fractures in Acromegaly Resistant to First-generation SRLs 8
Patients hospitalized with COVID-19 have low levels of 25-hydroxyvitamin D 8
GH-releasing peptides and bone 8
Active acromegaly enhances spontaneous parathyroid hormone pulsatility. 8
Mechanisms of anabolic therapies for osteoporosis. 8
Glucocorticoid inhibition of growth in rats: partial reversal with somatostatin antibodies. 8
Low-dose acyclovir and acute renal failure. 8
Insulin and GH-IGF-I axis: endocrine pacer or endocrine disruptor? 8
Cardiovascular risk in aging and obesity: is there a role for GH. 8
Pyridostigmine enhances even if it does not normalize the growth hormone responses to growth hormone-releasing hormone in patients with Cushing's disease. 8
Growth, insulin-like growth factor I (IGF-I), and IGF-binding proteins 1 and 3 in children with severe liver disease before and after liver transplantation: a longitudinal and cross-sectional study 8
Development of type II autoimmune polyglandular syndrome in a patient with idiopathic thrombocytopenic purpura. 8
[Acute torsion of the omentum majus. A case report]. 8
Effect of galanin on the growth hormone response to growth hormone-releasing hormone in acromegaly. 8
Safety and efficacy of oral octreotide in acromegaly: results of a multicenter phase III trial 8
Totale 1.485
Categoria #
all - tutte 65.084
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.084


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201 1 0 0 0 0 0 0 0 0 0 0 0
2020/202135 1 0 1 11 0 10 11 0 0 1 0 0
2021/2022124 0 0 0 50 7 10 5 21 10 4 4 13
2022/20231.815 856 349 139 20 10 166 79 102 48 3 11 32
2023/20241.068 40 116 166 149 116 267 59 103 6 40 6 0
Totale 3.112